Xcout Intel
Pretzel Therapeutics
Pretzel Therapeutics is a biotechnology company headquartered in Boston, Massachusetts, advancing a new class of medicines that target cellular energetics and mitochondrial function.
Subscribe to see Pretzel Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Pretzel Therapeutics at a glance
Pretzel Therapeutics is a biotech company headquartered in United States. Its most recent funding round, Series A, raised $72.5M in September 2022. Xcout tracks 6 named people at Pretzel Therapeutics, including Jay Parrish, Ph.D. (Chief Executive Officer & Chairman of the Board).
Pretzel Therapeutics leadership
- Jay Parrish, Ph.D.Chief Executive Officer & Chairman of the Board
- Baruch Harris, Ph.D.Chief Operating Officer
- Gabriel Martinez, Ph.D.Chief Scientific Officer & Co-Founder
- Claes Gustafsson, M.D., Ph.D.Co-Founder
- Maria Falkenberg, Ph.D.Co-Founder
- Michal Minczuk, Ph.D.Co-Founder
Pretzel Therapeutics funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $72.5M | 2 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Pretzel Therapeutics competitors
A few of Pretzel Therapeutics's closest competitors — see the full list of competitors and alternatives →
Flare Therapeutics is a biotechnology company headquartered in Cambridge, Massachusetts, focused on pioneering precision therapeutics.
Proximity Therapeutics, Inc. is a privately held biopharmaceutical and biotechnology company based in Cambridge, Massachusetts, founded in 2021. The neuro space company operates as a provider of biotechnology and develops next-generation medicines by controlling biological processes through proximity.
Ethyreal Bio is a biotechnology company headquartered in Cambridge, Massachusetts, focused on developing precision therapies for thyroid diseases with high unmet medical needs.
ScandiBio Therapeutics is a clinical-stage biotechnology company headquartered in Stockholm, Sweden, founded to develop pharmaceutical drugs targeting mitochondrial dysfunction.
Kinaset Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in Boston, Massachusetts, focused on developing novel therapeutics.
Get Pretzel Therapeutics's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Pretzel Therapeutics in Xcout Intel
- 6 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access